<html>
<head>
<title>A new lawsuit alleges anti-aging startup Elysium Health hasn't paid its sole supplier | TechCrunch</title>
<link href="../Styles/Style.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<h1 class="translated">一项新的诉讼称抗衰老初创公司Elysium Health没有向其唯一供应商TechCrunch付款</h1>
<blockquote>原文：<a href="https://web.archive.org/web/https://techcrunch.com/2017/01/16/a-new-lawsuit-alleges-anti-aging-startup-elysium-health-hasnt-paid-its-supplier-and-is-in-breach-of-agreement/amp/">https://web.archive.org/web/https://techcrunch.com/2017/01/16/a-new-lawsuit-alleges-anti-aging-startup-elysium-health-hasnt-paid-its-supplier-and-is-in-breach-of-agreement/amp/</a></blockquote><div><div class="content">

			
	
		
		

		<p class="amp-featured-image translated"><amp-img src="https://web.archive.org/web/20230223014633im_/https://techcrunch.com/wp-content/uploads/2016/12/og-image.jpg?w=1000" class="attachment-post-thumbnail size-post-thumbnail wp-post-image amp-wp-enforced-sizes i-amphtml-layout-intrinsic i-amphtml-layout-size-defined" alt="" srcset="https://web.archive.org/web/20230223014633im_/https://techcrunch.com/wp-content/uploads/2016/12/og-image.jpg 1000w, https://web.archive.org/web/20230223014633im_/https://techcrunch.com/wp-content/uploads/2016/12/og-image.jpg?resize=150,100 150w, https://web.archive.org/web/20230223014633im_/https://techcrunch.com/wp-content/uploads/2016/12/og-image.jpg?resize=300,200 300w, https://web.archive.org/web/20230223014633im_/https://techcrunch.com/wp-content/uploads/2016/12/og-image.jpg?resize=768,512 768w, https://web.archive.org/web/20230223014633im_/https://techcrunch.com/wp-content/uploads/2016/12/og-image.jpg?resize=680,454 680w, https://web.archive.org/web/20230223014633im_/https://techcrunch.com/wp-content/uploads/2016/12/og-image.jpg?resize=50,33 50w" layout="intrinsic" i-amphtml-layout="intrinsic"> <i-amphtml-sizer class="i-amphtml-sizer"> <img alt="" aria-hidden="true" class="i-amphtml-intrinsic-sizer" role="presentation" src=""/> </i-amphtml-sizer> <noscript> <img src="../Images/ace78b4d49d133ee3ec49dfcff89dd2c.png" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://web.archive.org/web/20230223014633im_/https://techcrunch.com/wp-content/uploads/2016/12/og-image.jpg 1000w, https://web.archive.org/web/20230223014633im_/https://techcrunch.com/wp-content/uploads/2016/12/og-image.jpg?resize=150,100 150w, https://web.archive.org/web/20230223014633im_/https://techcrunch.com/wp-content/uploads/2016/12/og-image.jpg?resize=300,200 300w, https://web.archive.org/web/20230223014633im_/https://techcrunch.com/wp-content/uploads/2016/12/og-image.jpg?resize=768,512 768w, https://web.archive.org/web/20230223014633im_/https://techcrunch.com/wp-content/uploads/2016/12/og-image.jpg?resize=680,454 680w, https://web.archive.org/web/20230223014633im_/https://techcrunch.com/wp-content/uploads/2016/12/og-image.jpg?resize=50,33 50w" sizes="(max-width: 1000px) 100vw, 1000px" data-original-src="https://web.archive.org/web/20230223014633im_/https://techcrunch.com/wp-content/uploads/2016/12/og-image.jpg?w=1000"/> </noscript> </amp-img></p><p class="translated"><strong>图片来源:</strong></p><p class="translated">Chromadex是抗衰老初创公司<a target="_blank" href="https://web.archive.org/web/20230223014633/https://www.elysiumhealth.com/"> Elysium Health </a>的两种主要产品成分紫檀芪和烟酰胺核苷(NR)的唯一供应商，它正在起诉这家初创公司未能就这些成分付款，并违反了商标和版税协议。</p>
<p class="translated">根据Chromadex网站上一份日期为2016年12月29日的<a target="_blank" href="https://web.archive.org/web/20230223014633/http://investors.chromadex.com/phoenix.zhtml?c=212121&amp;p=irol-SECText&amp;TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExMzE0MzE4JkRTRVE9MCZTRVE9MCZTUURFU0M9U0VDVElPTl9FTlRJUkUmc3Vic2lkPTU3">文件</a>，极乐世界做出虚假承诺和陈述，诱使ChromaDex提供大量的紫檀精和尼阿根</p>
<p class="translated">Elysium在其基础产品中使用紫檀芪和NR(或NIAGEN)——由ChromaDex制造的专利和专有成分。该诉讼称，Elysium同意在2014年2月通过ChromaDex订购这些产品。然而，这家初创公司在2014年6月后不久未能付款，据称违反了协议。</p>
<p class="translated">ChromaDex通常以NIAGEN商标向大约12个消费品牌提供NR成分，但它与Elysium达成了一项特殊协议，因此这家初创公司不必提及其成分的来源。该文件进一步指控Elysium未能支付并违反了NIAGEN产品的商标和版税协议，现在ChromaDex正在寻求“惩罚性损害赔偿、金钱损害赔偿和利息”，具体金额不详，诉讼称。</p>
<p class="translated">尽管存在不付款的问题，但这两家公司似乎继续保持着合作关系。然后，Elysium在2016年6月突然将Chromadex的产品订单增加了四倍。</p>
<p class="translated">Elysium在更大的6月份订单中要求的价格大约是最初商定金额的一半，ChromaDex表示，Elysium应该知道更低的价格不会被接受。ChromaDex表示，它已经与Elysium讨论了此事，诉讼称，Elysium虽然不高兴，但同意订购更多。</p>
<p class="translated">然后，Elysium于去年8月聘请了ChromaDex的业务发展副总裁马克·莫里斯(Mark Morris)，任命他为Elysium的新科技主管。此后，极乐世界停止向该公司订购。</p>
<p class="translated">该诉讼称，ChromaDex首席执行官弗兰克·雅克什(Frank Jaksch)试图解决这些和不付款问题，但Elysium无视他的努力。</p>
<p class="translated">ChromaDex拒绝对该诉讼置评，只是表示，根据SEC的公开备案记录，该诉讼已经提交并在其网站上列出。</p>
<p class="translated">这场法律诉讼给极乐世界带来了一个严重的问题。ChromaDex是NR的唯一来源。如前所述，这是市场上唯一的产品Basis中仅有的两种成分之一。</p>
<p class="translated">此外，极乐世界已经花费时间和资源开始研究这两种成分及其对人类的影响。</p>
<p class="translated">尽管Elysium将其基础产品标榜为一种“支持细胞长期健康”的药丸，但它不知道它最初在人类身上是否有效，因为这两种成分的研究此前只在老鼠身上进行过。此后，该公司对120名年龄在60岁至80岁之间的人进行了小规模抽样调查。</p>
<p class="translated">Elysium现在表示，初步测试证明其成分有效(改善和增加NAD+水平40%)。NAD+解释起来有点复杂，但它被认为是细胞抗衰老的前体，Elysium说它的成分增加了这些水平。除了极乐世界之外，现在至少还有其他人类临床试验正在进行，以观察NR是否对人类有任何抗衰老作用。</p>
<p class="translated">但是一旦供应耗尽，极乐世界可能无法继续测试。那它会做什么？有许多其他抗衰老补充剂，该公司可能会放弃其专有供应，但就在该公司似乎正在加速发展的时候，这浪费了大量的时间和精力(以及营销费用)。</p>
<p class="translated">我们已经联系了极乐世界，但是还没有回音。如果有消息，我们会及时通知你。</p>
<p class="translated"><i> <b>更新自极乐世界代言人:</b> </i></p>
<p class="translated">“虽然我们不对诉讼发表评论，但你可以补充说，我们的客户可以对我们现在和未来为他们提供基础的能力有100%的信心。”</p>
<p class="translated">这是否意味着极乐世界将在未来提供不同的成分？谁知道呢，但NIAGEN是一种专利产品，所以在供应耗尽后，初创公司不太可能会使用NR。</p>

		

			
	
		

			<amp-pixel src="https://web.archive.org/web/20230223014633im_/https://ampmetrics.techcrunch.com/pixel.gif" placeholder="" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>
		<amp-analytics data-credentials="include" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed">
		
	</amp-analytics>
	<amp-pixel src="https://web.archive.org/web/20230223014633im_/https://pixel.wp.com/g.gif?v=ext&amp;blog=136296444&amp;post=1439045&amp;tz=-8&amp;srv=techcrunch.com&amp;host=techcrunch.com&amp;rand=RANDOM&amp;ref=DOCUMENT_REFERRER" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_googleanalytics" type="googleanalytics" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_comscore" type="comscore" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_parsely" type="parsely" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>	</div>

</div>    
</body>
</html>